Evidence map›Paper›PMID 41074705›Full record

ArticleJournal of the International AIDS Society2025

Incidence and outcomes of anal and cervical cancer among adults with HIV in Latin America: a retrospective cohort study.

Rachael A Pellegrino, Shengxin Tu, Rodrigo Ville-Benavides, Emilia M Jalil, Staci L Sudenga, Brenda Crabtree-Ramírez, Claudia P Cortes, Diana Varela, Genevieve Hilaire, Cynthia Riviere and 5 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rachael A PellegrinoDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID https://orcid.org/0000-0002-7111-3040
Shengxin TuDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Rodrigo Ville-BenavidesDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Emilia M JalilInstituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0001-6017-5660
Staci L SudengaDivision of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Brenda Crabtree-RamírezDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-2587-1123
Claudia P CortesFundación Arriarán and University of Chile School of Medicine, Santiago, Chile.ORCID https://orcid.org/0000-0001-9101-9783
Diana VarelaServicio de Atención Integral del Hospital Escuela, Tegucigalpa, Honduras.
Genevieve HilaireLes Centres GHESKIO, Port-au-Prince, Haïti.
Cynthia RiviereLes Centres GHESKIO, Port-au-Prince, Haïti.
Eduardo GotuzzoUniversidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt, Lima, Peru.
Bryan E ShepherdDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Valeria FinkResearch Department, Fundacion Huesped, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0003-3994-4781
Jessica L CastilhoDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID https://orcid.org/0000-0002-7599-8173
Caribbean, Central and South America network for HIV Epidemiology

Funding

CCASAnet: Caribbean, Central and South America NetworkU01AI069923 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Pedro Enrique Cahn, Jessica L Castilho · 2006 to 2026
$41.6M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
NCATS NIH HHS UL1TR000445NIAID NIH HHS U01 AI069923NIH HHS 5K12CA090625-25NIH HHS 5T32AI007474-29NIH HHS U01AI069923NIH HHS UL1TR000445
6 · The paper itself

Abstract

introductionHuman papillomavirus (HPV)-associated cervical and anal cancers disproportionately affect people with HIV (PWH). This study aimed to determine the incidence trends of and risk factors for these malignancies in PWH in Latin America.

methodsWe included PWH from the Caribbean, Central and South America network for HIV epidemiology (CCASAnet) who contributed person-time between 2000 and 2019. We calculated crude and age-standardized incidence rates, examining trends over time with Poisson regression. Adjusted hazard ratios were calculated using Cox proportional hazard models with propensity score adjustment. We calculated the probability of survival after cancer diagnosis using Kaplan-Meier curves. To understand factors that influence our results, we surveyed all adult CCASAnet sites on current practices of cervical and anal cancer screening.

resultsOverall, 5739 females with HIV (43,417 person-years) were included in cervical cancer analyses. There were 27 incident cervical cancers: crude incidence rate of 62.2 (95% confidence interval [CI]: 34.9-89.4) per 100,000 person years. In the anal cancer analysis, 12,489 males who have sex with men (MSM), 7324 males other than MSM and 5739 females were included for a total of 25,552 PWH, contributing 157,166 person-years. Anal cancer was diagnosed in 56 individuals: crude incidence rates of 59.1 [95% CI: 33.2-85.0], 20.7 [95% CI: 11.6-29.7] and 15.2 [95% CI: 8.6-21.9] per 100,000 person-years in MSM, females and males other than MSM, respectively. Age-standardized incidence rates did not significantly change over time. Anal cancer risk decreased significantly with higher time-updated CD4 cell count. The predicted probability of 5-year survival after cancer diagnosis was 72.6% (95% CI: 48.4-86.8) for cervical cancer and 58.5% (95% CI: 44.0-70.5) for anal cancer.

conclusionsIn one of the few reports outside the United States or Europe, we did not observe a decrease in age-standardized incidence rates for anal and cervical cancer between 2000 and 2019. These data support continued efforts for cancer prevention through access to gender-neutral HPV vaccination and cancer screening.

Indexed as

Anus NeoplasmsHIV InfectionsUterine Cervical NeoplasmsAdultFemaleHumansIncidenceLatin AmericaMaleMiddle AgedPapillomavirus InfectionsRetrospective StudiesRisk FactorsYoung Adultanal cancercancer screeningcervical cancerHIVincidenceLatin America

Identifiers

PMID41074705
PMCPMC12514557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.